# Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

> **NCT01322386** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 32 (actual)

## Conditions studied

- Primary Sclerosing Cholangitis
- Biliary Atresia

## Interventions

- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT01322386
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-10
- **Final completion:** 2012-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01322386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01322386, "Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01322386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*